Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control
Authors:
Open Access
- 8 December 2025
- journal article
- research article
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (12) , 2531-2547
Abstract
The global type 2 diabetes epidemic is a major health crisis. Although the microbiome has roles in the onset of insulin resistance (IR), low-grade inflammation and diabetes, the microbial compounds controlling these processes remain to be discovered. Here, we show that the microbial metabolite trimethylamine (TMA) decouples inflammation and IR from diet-induced obesity by inhibiting interleukin-1 receptor-associated kinase 4 (IRAK4), a central kinase in the Toll-like receptor pathway sensing danger signals. TMA blunts TLR4 signalling in primary human hepatocytes and peripheral blood monocytic cells and rescues mouse survival after lipopolysaccharide-induced septic shock. Genetic deletion and chemical inhibition of IRAK4 result in metabolic and immune improvements in high-fat diets. Remarkably, our results suggest that TMA—unlike its liver co-metabolite trimethylamine N -oxide, which is associated with cardiovascular disease—improves immune tone and glycemic control in diet-induced obesity. Altogether, this study supports the emerging role of the kinome in the microbial–mammalian chemical crosstalk.Keywords
All Related Versions
This publication has 85 references indexed in Scilit:
- Sequential Autophosphorylation Steps in the Interleukin-1 Receptor-associated Kinase-1 Regulate its Availability as an Adapter in Interleukin-1 SignalingJournal of Biological Chemistry, 2004
- Pyogenic Bacterial Infections in Humans with IRAK-4 DeficiencyScience, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4Nature, 2002
- Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care, 1999
- Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndromeNature Genetics, 1997
- Effect of dietary intake of trimethylamine on human metabolism of the industrial catalyst dimethylethylamine.Occupational and Environmental Medicine, 1995
- The exogenous origin of trimethylamine in the mouseMetabolism, 1992
- Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: A pharmacogenetic approachClinical Pharmacology & Therapeutics, 1987
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973